Upcoming Mega Pharmaceutical Project in Uttar Pradesh — featuring advanced Biosimilars and Monoclonal Antibodies (mAbs) capabilities || Integrated Pharmaceuticals Excellence — From R&D, APIs & Formulations to Biosimilars & mAbs
Career Enquiry:
+91-7807836763
Business Enquiry:
+91-7807096343
biozenta@gmail.com
Home
Company Profile
Vision and Mission
About Us
Management & Leadership
Business Value
Vision 2030
Infrastructure
Manufacturing
Packaging
R & D
API Development
Quality Control
Accreditations
Products
Biozenta Formulation
Biozenta Ethicaz
Oncology
Liquid Injection
Lyophilized
PFS
Tablets
Capsules
General
Injection
Lyophilized
PFS
Contrast Media
Tablets
Capsules
Biozenta Genericaz
Biozenta API
API List
INT List
Biozenta Farmacia
Liquid Injectables
Lyophilized Injectables
Tablets
Capsules
Global Presence
Services
Manufacturing Support
Institutional Tenders
Regulatory Service
Why us?
Events
Texfer
Career
Contact Us
Request A Call Back
Submit
Register Drug Shortage
Online Enquiry
Job Opportunities
Lyophilized
Home
Lyophilized
LYOPHILIZED PRODUCTS
GEMCITABINE
ZOLEDRONIC ACID
DOXORUBICIN HYDROCHLORIDE
PACLITAXEL (protein bound particle)
GANCICLOVIR
PEMETREXED
BORTEZOMIB
PEG-ASPARAGENASE
EPIRUBICIN HYDROCHLORIDE
FLUDARABINE PHOSPHATE
DACARBAZINE
BENDAMUSTIN
OXALIPLATIN
IDARUBICIN HYDROCHLORIDE
BLEOMYCIN SULFATE
MELPHALAN
DECITABINE
AZACITIDINE
CYCLOPHOSPHAMIDE
PAMIDRONATE DISODIUM
IFOSFAMIDE
CARMUSTINE
MITOMYCIN
METHOTREXATE
DEGARELIX
VINCRISTINE SULPHATE
LEUPROLIDE ACETATE
TOPOTECAN HYDROCHLORIDE
AMIFOSTINE
DAUNORUBICIN CITRATE
AMPHOTERICIN-B LIPOSOMAL
TRIPTORELIN ACETATE
CARFILZOMIB
DACTINOMYCIN
GOSERLIN ACETATE
DACARBAZINE
VINBLASTINE SULPHATE
CARBOPLATIN
DOXORUBICIN HYDROCHLORIDE LIPOSOME
